Filing Details
- Accession Number:
- 0001562180-22-004887
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-07 19:03:56
- Reporting Period:
- 2022-06-03
- Accepted Time:
- 2022-06-07 19:03:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1710072 | Edgewise Therapeutics Inc. | EWTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1191702 | R John Moore | C/O Edgewise Therapeutics, Inc. 3145 Colorado Ave Boulder CO 80303 | General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-06-03 | 15,230 | $1.93 | 18,230 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-06-03 | 15,230 | $6.05 | 3,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-06-06 | 13,934 | $1.93 | 16,934 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-06-06 | 13,934 | $6.03 | 3,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-06-07 | 973 | $1.93 | 3,973 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-06-07 | 973 | $6.61 | 3,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-06-07 | 17,150 | $0.71 | 20,150 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-06-07 | 17,150 | $6.61 | 3,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-06-03 | 15,230 | $0.00 | 15,230 | $1.93 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-06-06 | 13,934 | $0.00 | 13,934 | $1.93 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-06-07 | 973 | $0.00 | 973 | $1.93 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-06-07 | 17,150 | $0.00 | 17,150 | $0.71 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 211,828 | 2030-12-15 | No | 4 | M | Direct | |
| 197,894 | 2030-12-15 | No | 4 | M | Direct | |
| 196,921 | 2030-12-15 | No | 4 | M | Direct | |
| 188,172 | 2030-09-01 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on March 16, 2022.
- Includes 1,438 shares purchased on May 16, 2022 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan.
- The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.12, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.18, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $6.01 to $6.91, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- 1/48th of the shares subject to the option vest each month beginning on January 16, 2021, subject to the Reporting Person continuing as a service provider through each vest date.
- 1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date.
Billionaire Hedge Funds
